Effect of a Driving Pressure-limiting Strategy for Patients With acute Respiratory Distress Syndrome Secondary to Community-acquired Pneumonia: the STAMINA Randomised Clinical Trial

Background: This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the number of ventilator-free days within 28 days in patients with moderate to severe acute respiratory distress syndrome (ARDS).

Methods: This is a multi-centre, randomised trial, enrolling adults with moderate to severe ARDS secondary to community-acquired pneumonia. Patients were randomised to a driving pressure-limiting strategy or low PEEP strategy based on a PEEP:FiO table. All patients received volume assist-control mode until day 3 or when considered ready for spontaneous modes of ventilation. The primary outcome was ventilator-free days within 28 days. Secondary outcomes were in-hospital and intensive care unit mortality at 90 days.

Results: The trial was stopped because of recruitment fatigue after 214 patients were randomised. In total, 198 patients (n=96 intervention group, n=102 control group) were available for analysis (median age 63 yr, [interquartile range 47-73 yr]; 36% were women). The mean difference in driving pressure up to day 3 between the intervention and control groups was -0.7 cm HO (95% confidence interval -1.4 to -0.1 cm HO). Mean ventilator-free days were 6 (sd 9) in the driving pressure-limiting strategy group and 7 (9) in the control group (proportional odds ratio 0.72, 95% confidence interval 0.39-1.32; P=0.28). There were no significant differences regarding secondary outcomes.

Conclusions: In patients with moderate to severe ARDS secondary to community-acquired pneumonia, a driving pressure-limiting strategy did not increase the number of ventilator-free days compared with a standard low PEEP strategy within 28 days.

Clinical Trial Registration: NCT04972318.

References

Brower R, Matthay M, Morris A, Schoenfeld D, Thompson B, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8. DOI: 10.1056/NEJM200005043421801. View

Costa E, Alcala G, Tucci M, Goligher E, Morais C, Dianti J . Impact of extended lung protection during mechanical ventilation on lung recovery in patients with COVID-19 ARDS: a phase II randomized controlled trial. Ann Intensive Care. 2024; 14(1):85. PMC: 11161454. DOI: 10.1186/s13613-024-01297-z. View

Sahetya S . Searching for the optimal positive end-expiratory pressure for lung protective ventilation. Curr Opin Crit Care. 2019; 26(1):53-58. DOI: 10.1097/MCC.0000000000000685. View

Shaver C, Bastarache J . Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury. Clin Chest Med. 2014; 35(4):639-53. PMC: 4254695. DOI: 10.1016/j.ccm.2014.08.004. View

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010; 7(3):e1000251. PMC: 2844794. DOI: 10.1371/journal.pmed.1000251. View

Calfee C, Delucchi K, Parsons P, Thompson B, Ware L, Matthay M . Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014; 2(8):611-20. PMC: 4154544. DOI: 10.1016/S2213-2600(14)70097-9. View

Biasi Cavalcanti A, Suzumura E, Laranjeira L, Paisani D, Damiani L, Guimaraes H . Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2017; 318(14):1335-1345. PMC: 5710484. DOI: 10.1001/jama.2017.14171. View

Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. DOI: 10.1001/jama.2012.5669. View

Romano M, Maia I, Laranjeira L, Damiani L, Paisani D, Borges M . Driving Pressure-limited Strategy for Patients with Acute Respiratory Distress Syndrome. A Pilot Randomized Clinical Trial. Ann Am Thorac Soc. 2020; 17(5):596-604. DOI: 10.1513/AnnalsATS.201907-506OC. View

10.

Dianti J, McNamee J, Slutsky A, Fan E, Ferguson N, McAuley D . Determinants of Effect of Extracorporeal CO Removal in Hypoxemic Respiratory Failure. NEJM Evid. 2024; 2(5):EVIDoa2200295. DOI: 10.1056/EVIDoa2200295. View

11.

Kacmarek R, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J . Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial. Crit Care Med. 2015; 44(1):32-42. DOI: 10.1097/CCM.0000000000001383. View

12.

Pelosi P, DOnofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi V . Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003; 42:48s-56s. DOI: 10.1183/09031936.03.00420803. View

13.

Fan E, Brodie D, Slutsky A . Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018; 319(7):698-710. DOI: 10.1001/jama.2017.21907. View

14.

Zampieri F, Costa E, Iwashyna T, Carvalho C, Damiani L, Taniguchi L . Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial. Br J Anaesth. 2019; 123(1):88-95. DOI: 10.1016/j.bja.2019.02.026. View

15.

Slutsky A, Ranieri V . Ventilator-induced lung injury. N Engl J Med. 2013; 369(22):2126-36. DOI: 10.1056/NEJMra1208707. View

16.

Richard J, Terzi N, Yonis H, Chorfa F, Wallet F, Dupuis C . Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial. Lancet Respir Med. 2023; 11(11):991-1002. DOI: 10.1016/S2213-2600(23)00221-7. View

17.

Richard J, Marque S, Gros A, Muller M, Prat G, Beduneau G . Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients. Intensive Care Med. 2019; 45(11):1590-1598. DOI: 10.1007/s00134-019-05776-x. View

18.

Calfee C, Janz D, Bernard G, May A, Kangelaris K, Matthay M . Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015; 147(6):1539-1548. PMC: 4451708. DOI: 10.1378/chest.14-2454. View

19.

McNamee J, Gillies M, Barrett N, Perkins G, Tunnicliffe W, Young D . Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA. 2021; 326(11):1013-1023. PMC: 8408762. DOI: 10.1001/jama.2021.13374. View

20.

Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View